From: Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis
Number of studies | HR (95% CI) | Heterogeneity | Favor | |
---|---|---|---|---|
Overall survival | 3 | 1.63 (1.38, 1.93), P < 0.00001 | I2 = 0% | SR |
Progression-free survival | 2 | 1.69 (1.31, 2.18), P < 0.00001 | I2 = 0% | SR |
Cancer-specific survival | 2 | 1.72 (1.36, 2.18), P < 0.00001 | I2 = 0% | SR |